Data as of Dec 19
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 21.88, with a high estimate of 25.00 and a low estimate of 18.75. The median estimate represents a +203.82% increase from the last price of 7.20.
The current consensus among 2 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.